# OnCo record tusamitamab-ravtansine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tusamitamab-ravtansine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tusamitamab-ravtansine" ;
  schema:name "Tusamitamab ravtansine"@en ;
  schema:description "Tusamitamab ravtansine was Sanofi's ADC against the classic CEA tumour marker, stopped for futility in lung cancer in 2023."@en ;
  schema:url <https://onco.cc/drugs/tusamitamab-ravtansine/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://www.sanofi.com/en/media-room/press-releases/2023/> ;
  onco:status "withdrawn" ;
  onco:tag "failure", "lesson:wrong-drug" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/ceacam5/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:trials <https://onco.cc/trials/nct04154956/>, <https://onco.cc/trials/nct04524689/>, <https://onco.cc/trials/nct04659603/> .